Bone Biologics Corp (BBLG)
1.19
-0.10
(-7.75%)
USD |
NASDAQ |
Nov 15, 16:00
1.24
+0.05
(+4.20%)
After-Hours: 20:00
Bone Biologics Research and Development Expense (TTM): 2.618M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.618M |
| March 31, 2024 | 4.563M |
| December 31, 2023 | 6.908M |
| September 30, 2023 | 7.217M |
| June 30, 2023 | 6.411M |
| March 31, 2023 | 4.134M |
| December 31, 2022 | 1.579M |
| September 30, 2022 | 0.8579M |
| June 30, 2022 | 0.0885M |
| March 31, 2022 | 0.0729M |
| December 31, 2021 | 0.082M |
| September 30, 2021 | 0.0692M |
| June 30, 2021 | 0.2121M |
| March 31, 2021 | 0.2191M |
| December 31, 2020 | 0.3407M |
| September 30, 2020 | 0.3873M |
| June 30, 2020 | 0.2894M |
| March 31, 2020 | 0.6979M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.095M |
| September 30, 2019 | 1.641M |
| June 30, 2019 | 0.5299M |
| March 31, 2019 | 0.2998M |
| December 31, 2018 | 0.1045M |
| September 30, 2018 | -0.1641M |
| June 30, 2018 | 1.136M |
| March 31, 2018 | -2.157M |
| December 31, 2017 | -1.334M |
| September 30, 2017 | 0.4527M |
| June 30, 2017 | 2.692M |
| March 31, 2017 | 8.116M |
| December 31, 2016 | 11.60M |
| September 30, 2016 | 12.47M |
| June 30, 2016 | 10.30M |
| March 31, 2016 | 8.157M |
| December 31, 2015 | 3.667M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.0692M
Minimum
Sep 2021
7.217M
Maximum
Sep 2023
1.992M
Average
0.6979M
Median
Mar 2020
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 16.41B |
| Dermata Therapeutics Inc | 5.648M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |